Login

Q2 2024 Market Trends and Q3 Outlook: A Comprehensive Review | David W. Shotwell, CEO, Shotwell Rutter Baer. 00:10:00

Share On Facebook Share On Twitter

Join David W. Shotwell, CEO of Shotwell Rutter Baer, as we delve into the market trends and economic indicators for Q2 2024 and preview the outlook for Q3. This in-depth analysis covers overall market performance, the role of tech stocks, bond market stability, and international stock market dynamics. We also examine the effects of unemployment rates, inflation, and consumer behavior on the economy.

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
Expanding Horizons: Financial Strength and Growth Strategy in Innovation, Biologics, and Consumer Care|Erez Israeli,Chief Executive Officer,Dr. Reddy's Laboratories Ltd
00:10:00
Mastering Alpha Creation: An Exclusive Conversation with Sunil Singhania, Founder of Abakkus Asset Management LLP on ICICI Direct
00:10:00
Richard Byworth, CEO of Equinix Group, Reflects on a Year of Crypto Innovation and Institutional Adoption
00:10:00
Krzysztof Bajołek on How Answear.com is Attracting Investors | Krzysztof Bajołek, President , Answear.com SA.
00:10:00
Duke Energy CEO Lynn Good discusses recent data center demand and regulatory implications affecting the company's earnings on 'The Exchange'.
00:10:00
Antler specializes in local Founder Residencies, and invests in founders across industries|Ollie Forsyth,Global Community Manager,Antler
00:10:00
From Intel Intern to Food Tech Visionary: Funding, Challenges|Brian Frank,General Partner,FTW Ventures
00:10:00
John Zillmer and Kim Scott Discuss the Spin-Off Benefits and Future of Vestis | John Zillmer, CEO, Aramark.
00:10:00
you will have a much higher chance of success if your outreach is targeted|Daniel Gross,Founder, Pioneer.app
00:00:00
ImmuPharma CEO Tim McCarthy discusses financial stability and promising drug developments -Tim McCarthy, FCCA, MBA - Chief Executive Officer, ImmuPharma
00:10:00
Lumentum is acquiring rival laser maker Coherent for $5.7 billion in cash and stock, with Coherent shareholders receiving $100 in cash and 1.1851 shares of Lumentum stock per share.
00:10:00
Invest in companies led by women people of color|Arlan Hamilton, Managing Partner,Backstage Capital

© 2017 - Townhall + Tv